Streetbeat News

Price Targets

GLBE

Global E Online (NASDAQ:GLBE) has received various analyst ratings over the last quarter, with 6 bullish, 5 somewhat bullish, and 1 indifferent rating. The average 12-month price target among 12 analysts is $43.92, with a high of $54.00 and a low of $33.00, marking a 6.79% decrease from the previous target of $47.12.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 12:00 pm

HUBB

Over the last quarter, Hubbell (NYSE:HUBB) received 4 analyst ratings: 1 bullish, 2 somewhat bullish, and 1 indifferent. No bearish or somewhat bearish ratings were given. The 12-month price targets for Hubbell have an average of $340.00, with a high of $375.00 and a low of $325.00. The average price target has increased by 2.1% over the past month.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 12:00 pm

CNX

Over the past 3 months, 4 Wall Street analysts have provided ratings for CNX Resources (NYSE:CNX), with an average price target of $24.0, representing an implied upside from the current price of $21.5. The consensus includes 1 bullish, 2 indifferent, and 1 somewhat bearish rating. The average price target has increased by 18.05% over the past month.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 12:00 pm

CFG

Over the past 3 months, 8 Wall Street analysts have provided ratings for Citizens Financial Group (NYSE:CFG), with 5 somewhat bullish, 3 indifferent, and none bearish. The average 12-month price target for CFG is $31.62, with a high of $36.00 and a low of $26.00. This target has decreased by 3.21% from the previous target of $32.67. Analysts rate stocks to predict performance and provide guidance to traders, though it's important to remember these are forecasts and can vary.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 12:00 pm

COCP

HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a Buy rating on Cocrystal Pharma (NASDAQ:COCP) and maintained a $12 price target on the stock.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 11:59 am

KZR

HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a Buy rating on Kezar Life Sciences (NASDAQ:KZR) and maintained a $20 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 11:56 am

SCLX

HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a Buy rating on Scilex Holding (NASDAQ:SCLX) and maintained a $12 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 11:54 am

KRRO

HC Wainwright & Co. analyst Mitchell Kapoor has initiated coverage on Korro Bio (NASDAQ:KRRO) with a Buy rating and set a price target of $100 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 11:50 am

GLBE

Needham analyst Scott Berg has reiterated a Buy rating on Global E Online (NASDAQ: GLBE) and maintained a $48 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 11:49 am

GANX

HC Wainwright & Co. analyst Raghuram Selvaraju has maintained a Buy rating on Gain Therapeutics (NASDAQ:GANX) but has reduced the price target from $10 to $9.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 11:47 am